CAMP Camp4 Therapeutics Corp
Nasdaq · SEC CIK 1736730 · EDGAR
- Bought, last 12 months
- $99.1K 5 purchases by 4 insiders
- Sold, last 12 months
- $2.50M 4 sales by 2 insiders
- Filings on record
- 59 since 2024-10-15, latest 2026-09-02 19:50
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Schwab Andrew J. | Dir | — | $2.50M |
| Gold Kelly | CFO | $50.4K | — |
| Young Richard A | Dir | $27.0K | — |
| Mandel-Brehm Josh | CEO, Dir | $10.8K | — |
| Maricich Yuri | Chief Medical Off | $10.8K | — |
| Tardiff Daniel | CSO | — | $8,273 |
Transactions 36
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-09-02 19:50 | 2026-08-31 | CAMP | Gold Kelly | CFO | P - Purchase | $3.96 | +10.0K | 10.0K | New | +$39.6K |
| I | 2026-08-31 17:05 | 2026-08-27 | CAMP | Schwab Andrew J. | Dir | S - Sale | $4.04 | -400.0K | 2.03M | -16% | -$1.62M |
| I | 2026-08-26 16:57 | 2026-08-24 | CAMP | Schwab Andrew J. | Dir | S - Sale | $4.50 | -10 | 2.43M | -0.0% | -$45 |
| MI | 2026-08-21 16:59 | 2026-08-19+ | CAMP | Schwab Andrew J. | Dir | S - Sale | $4.59 | -191.9K | 2.43M | -7% | -$879.7K |
| 2026-08-19 20:46 | 2026-08-19 | CAMP | Tardiff Daniel | CSO | S - Sale | $4.76 | -1,738 | 0 | -100% | -$8,273 | |
| 2026-08-05 17:09 | 2026-08-03 | CAMP | Young Richard A | Dir | P - Purchase | $1.65 | +16.4K | 186.4K | +10% | +$27.0K | |
| 2026-08-05 17:08 | 2026-08-03 | CAMP | Maricich Yuri | Chief Medical Off | P - Purchase | $1.65 | +6,551 | 12.6K | +108% | +$10.8K | |
| 2026-08-05 17:08 | 2026-08-03 | CAMP | Gold Kelly | CFO | P - Purchase | $1.65 | +6,551 | 74.4K | +10% | +$10.8K | |
| 2026-08-05 17:07 | 2026-08-03 | CAMP | Mandel-Brehm Josh | CEO, Dir | P - Purchase | $1.65 | +6,551 | 285.0K | +2% | +$10.8K | |
| I | 2025-09-15 | 2025-09-11 | CAMP | Schwab Andrew J. | Dir, 10% | A - Grant | $1.53 | +2.94M | 2.94M | New | +$4.50M |
| I | 2025-09-15 | 2025-09-11 | CAMP | 5AM Ventures VII, L.P. | 10% | P - Purchase | $1.53 | +2.94M | 2.94M | New | +$4.50M |
| 2025-09-11 | 2025-09-11 | CAMP | Maricich Yuri | Chief Medical Off | P - Purchase | $1.65 | +6,060 | 6,060 | New | +$9,999 | |
| 2025-09-11 | 2025-09-11 | CAMP | Mandel-Brehm Josh | CEO, Dir | P - Purchase | $1.65 | +6,060 | 278.4K | +2% | +$9,999 | |
| 2025-09-11 | 2025-09-11 | CAMP | Young Richard A | Dir | P - Purchase | $1.65 | +15.2K | 170.0K | +10% | +$25.0K | |
| 2025-09-11 | 2025-09-11 | CAMP | Gold Kelly | CFO | P - Purchase | $1.65 | +6,060 | 67.9K | +10% | +$9,999 | |
| MI | 2025-09-11 | 2025-09-11 | CAMP | Nashat Amir | Dir, 10% | P - Purchase | $1.53 | +1.31M | 197.7K | New | +$2.00M |
| MI | 2025-09-11 | 2025-09-11 | CAMP | Polaris Management Co. VII, L.L.C. | 10% | P - Purchase | $1.53 | +1.31M | 2.83M | +86% | +$2.00M |
| DAI | 2024-10-22 | 2024-10-15 | CAMP | Polaris Management Co. VII, L.L.C. | 10% | P - Purchase | $11.00 | +909.1K | 909.1K | New | +$10.00M |
| DMAI | 2024-10-22 | 2024-10-15 | CAMP | Polaris Management Co. VII, L.L.C. | 10% | C - Cnv Deriv | — | +1.72M | 112.2K | New | — |
| DI | 2024-10-17 | 2024-10-15 | CAMP | Everest Aggregator, LP | 10% | C - Cnv Deriv | — | +2.42M | 2.42M | New | — |
| DI | 2024-10-17 | 2024-10-15 | CAMP | Everest Aggregator, LP | 10% | P - Purchase | $11.00 | +1.36M | 3.79M | +56% | +$15.00M |
| DMI | 2024-10-17 | 2024-10-15 | CAMP | Northpond Ventures II, LP | 10% | C - Cnv Deriv | — | +1.47M | 471.4K | New | — |
| DI | 2024-10-17 | 2024-10-15 | CAMP | Northpond Ventures II, LP | 10% | P - Purchase | $11.00 | +763.6K | 763.6K | New | +$8.40M |
| DMI | 2024-10-17 | 2024-10-15 | CAMP | AH Equity Partners Bio I, L.L.C. | 10% | P - Purchase | $11.00 | +727.3K | 545.5K | New | +$8.00M |
| DI | 2024-10-17 | 2024-10-15 | CAMP | AH Equity Partners Bio I, L.L.C. | 10% | C - Cnv Deriv | — | +1.40M | 1.40M | New | — |
| DI | 2024-10-15 | 2024-10-15 | CAMP | Nashat Amir | Dir, 10% | P - Purchase | $11.00 | +909.1K | 909.1K | New | +$10.00M |
| DMI | 2024-10-15 | 2024-10-15 | CAMP | Nashat Amir | Dir, 10% | C - Cnv Deriv | — | +1.72M | 112.2K | New | — |
| DMI | 2024-10-15 | 2024-10-15 | CAMP | 5AM Opportunities II, L.P. | 10% | C - Cnv Deriv | — | +2.02M | 302.8K | New | — |
| DI | 2024-10-15 | 2024-10-15 | CAMP | 5AM Opportunities II, L.P. | 10% | P - Purchase | $11.00 | +909.1K | 2.63M | +53% | +$10.00M |
| DMI | 2024-10-15 | 2024-10-15 | CAMP | Schwab Andrew J. | Dir, 10% | C - Cnv Deriv | — | +2.02M | 1.34M | New | — |
| DI | 2024-10-15 | 2024-10-15 | CAMP | Schwab Andrew J. | Dir, 10% | P - Purchase | $11.00 | +909.1K | 2.63M | +53% | +$10.00M |
| D | 2024-10-15 | 2024-10-15 | CAMP | Mandel-Brehm Josh | CEO, Dir | C - Cnv Deriv | — | +605 | 272.4K | +0.2% | — |
| D | 2024-10-15 | 2024-10-15 | CAMP | Young Richard A | Dir | C - Cnv Deriv | — | +8,917 | 154.9K | +6% | — |
| D | 2024-10-15 | 2024-10-15 | CAMP | Holtzman Steven H | Dir | C - Cnv Deriv | — | +8,917 | 108.9K | +9% | — |
| DMI | 2024-10-15 | 2024-10-15 | CAMP | Polaris Partners VII, L.P. | 10% | C - Cnv Deriv | — | +1.72M | 1.60M | New | — |
| DI | 2024-10-15 | 2024-10-15 | CAMP | Polaris Partners VII, L.P. | 10% | P - Purchase | $11.00 | +909.1K | 909.1K | New | +$10.00M |
Purchase Sale Sale after option exercise All abbreviations